Acacia Pharma has a pipeline of near-market products targeting large and growing markets with significant unmet medical needs.
Postoperative nausea & vomiting (PONV)
PONV is a common complication of surgery, occurring in approximately 30% of surgical patients and up to 80% of high-risk patients.
View PONV video
For use during invasive medical procedures, such as colonoscopy and bronchoscopy.
Chemotherapy induced nausea & vomiting (CINV)
CINV is one of the most common and feared side effects of cancer chemotherapy.
Acacia Pharma Announces Debt for Equity Swap with Cosmo Pharmaceuticals
Alessandro Della Chà Appointed as Director of Acacia Pharma Group plc
Acacia Pharma Announces Brief Extension of FDA Review Period for NDA for BYFAVO™
View all news